Cravath-Led J&J Spinoff Kenvue Eyes $3.3B IPO
Johnson & Johnson's consumer health unit Kenvue Inc. on Monday set a price range on an initial public offering that could raise about $3.3 billion, potentially marking the largest IPO since...To view the full article, register now.
Already a subscriber? Click here to view full article